BERARDELLI, ERBUTO, and POMPILI: Department of Neurosciences, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy

AGUGLIA, AMERIO, PASTORINO, and SERAFINI: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, and Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino, Genoa, Italy

SARUBBI and ROGANTE: Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy

TROCCHIA, ZELLETTA, and LONGHINI: Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Psychiatry Unit, Sant’Andrea Hospital, Rome, Italy

LAMIS: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA

INNAMORATI: Department of Human Sciences, European University of Rome, Rome, Italy

In the past 2 years, M.P. has received honoraria for lectures or serving on advisory boards or engaged in clinical trial activities with Angelini Pharma, Lundbeck, Janssen, Pfizer, MSD, Fidia, Rovi and Recordati, which were unrelated to this study. The remaining authors declare no conflicts of interest.

Please send correspondence to: Isabella Berardelli, MD, PhD, Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035, Rome 00189, Italy (e-mail: [email protected]).